Trial Profile
Clinical Trials Insight: 700060609
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2010
Price :
$35
*
At a glance
- Drugs Aciclovir/hydrocortisone (Primary)
- Indications Herpes labialis
- Focus Adverse reactions
- 27 Oct 2010 Status changed from not stated to completed.
- 27 Oct 2010 New trial record
- 30 Sep 2010 Results reported at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), according to a Medivir AB media release.